MyFinsight
Home
Blog
About
Net loss
attributable to stockholders
-$5,481K
(-9.34%↓ Y/Y)
Net loss
attributable to...
-$42K
Sleep Testing
Services
$2,392K
(183.41%↑ Y/Y)
Treatment Centers
$767K
Myofunctional Therapy
Services
$337K
(106.75%↑ Y/Y)
Sponsorship Seminar Other
$161K
(-73.52%↓ Y/Y)
Billing Intelligence
Services
$129K
(-32.11%↓ Y/Y)
VIP
$12K
(-90.77%↓ Y/Y)
Revenue From Contract
With Customer...
$1,355K
(-28.12%↓ Y/Y)
Net loss
-$5,523K
(-10.17%↓ Y/Y)
Service
$3,798K
(96.28%↑ Y/Y)
Product
$1,355K
(-28.12%↓ Y/Y)
Loss before income
taxes
-$5,523K
(-10.17%↓ Y/Y)
Other income
$352K
(2246.67%↑ Y/Y)
Total revenue
$5,153K
(34.90%↑ Y/Y)
Operating loss
-$4,825K
(0.82%↑ Y/Y)
Other expense
-$1,050K
(-544.17%↓ Y/Y)
Gross profit
$2,953K
(39.95%↑ Y/Y)
Cost of sales
(exclusive of depreciation...
$2,200K
(28.65%↑ Y/Y)
Total operating
expenses
$7,778K
(11.51%↑ Y/Y)
General and
administrative
$7,113K
(10.98%↑ Y/Y)
Depreciation and
amortization
$510K
(66.67%↑ Y/Y)
Sales and marketing
$155K
(-40.38%↓ Y/Y)
Back
Back
Income Statement
Vivos Therapeutics, Inc. (VVOS)
Vivos Therapeutics, Inc. (VVOS)
source: myfinsight.com